NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors
Sign Up to like & getrecommendations! Published in 2020 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-19-0977
Abstract: XPO1 inhibitors have shown promise in cancer treatment, but mechanisms of resistance to these drugs are not well understood. In this study, we established selective inhibitors of nuclear export (SINE)-resistant ovarian cancer cell lines from… read more here.
Keywords: xpo1 inhibitors; nrg1 erbb3; cancer; resistance ... See more keywords